Our Protocols
Identifying prospective clinical trial candidates
Learn what clinical trial participation involves and whether it aligns with your needs, goals, and circumstances.
Our approach to safety in psychedelic therapy
Discover how our comprehensive care model protects both physical and psychological well-being.
Safety, agency, and recovery: trauma-informed care at Sunstone
Continuous informed consent, psychological safety, and individualized care are built into every step of the treatment process.
Advancing standards in MDMA psychedelic therapy research training
We are setting the industry standard for high quality training for mental health professionals in psychedelic therapy research.
Meet Dr. Manish Agrawal – Psychedelic Oncology Leader
Manish Agrawal, MD, brings an extensive academic, clinical, and research background and depth of experience to Sunstone.